09:00-10:30

Parallel 1a: Gene delivery platform

Chairs: Virginia Haurigot, Spark Therapeutics

09:00    Virginia Haurigot, Spark Therapeutics

INV01    AAV vectors, from basics to challenges

09:25    Xavier Anguela, Ask Bio ⓘ

INV02   Non-viral gene transfer for rare diseases

ABSTRACT >

09:50    Pedro Berraondo, Program of Immunology and Immunotherapy, Cima Universidad de Navarra  ⓘ

INV03    Advances in mRNA-based therapeutics

10:15    Round Table